Navigation Links
BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
Date:9/8/2010

LYNBROOK, N.Y., Sept. 8 /PRNewswire/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming Rodman & Renshaw 12th Annual Healthcare Conference on Wednesday, September 15, 2010, at 9:35am EDT.

A live webcast of the presentation can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at http://www.biospecifics.com, or you may use the link: http://www.wsw.com/webcast/rrshq18/bstc.

About BioSpecifics Technologies Corp.BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for eleven clinical indications, three of which include: Dupuytren's contracture, Peyronie's disease, and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium markets XIAFLEX in the U.S. for the treatment of Dupuytren's contracture. Pfizer, Inc. is responsible for marketing XIAFLEX in Europe. More information about BioSpecifics may be found on its website at http://www.biospecifics.com. Contact:BioSpecifics Technologies Corp.Thomas L. Wegman, President(516) 593-7000thomas_wegman@biospecifics.com
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
3. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
4. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
5. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
6. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
7. BioSpecifics Technologies Corp. Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytrens Disease
8. BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
9. BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
10. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
11. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- Aridis is ... reached with Switzerland -based Kenta ... human monoclonal antibody (mAb) products, and technologies. This ... products for treatment of infections by common pathogens ... aureus , Pseudomonas aeruginosa , Acinetobacter ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ ... help predict the adverse and therapeutic effects of a ... Computational Biology at the Genomics Laboratory, Covance, will discuss ... genomics when used as part of the QC process. ... sets to identify key clinical targets even in complex ...
(Date:5/17/2013)... May 17, 2013 IAC Industries wants to ... start up laboratory needing to set up and furnish a ... a larger facility within a year’s time. How does a ... the laboratory is temporary? What is efficient and cost-effective? ... workstations from IAC Industries. The planners at DisperSol determined that ...
(Date:5/16/2013)... ISPE announced today that ... the newly created position of Vice President of ... be responsible for stimulating ISPE’s revenue growth by ... Society’s Member-led and staff-driven business model, initiating integrated ... membership and product marketing. , “Barbara joins ISPE ...
Breaking Biology Technology:Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2
... In a step toward engineering ever-smaller electronic devices, ... Brookhaven National Laboratory have assembled nanoscale pairings of ... Composed of light-absorbing, colloidal quantum dots linked to ... convert light to electricity in a precisely controlled ...
... 2011 Neuralstem, Inc. (NYSEAmex: CUR )  reported ... March 31, 2011 and provided a business and clinical ... Company reached several major milestones in the first Quarter ... for ALS was presented at the American Academy of ...
... 10, 2011 The Laboratory Department for Probiotics ... Medicine (NAGATA Satoru, YAMASHIRO Yuichiro et al.) studied ... strain Shirota (LcS) in elderly individuals living at ... with acute norovirus gastroenteritis. Analysis ...
Cached Biology Technology:Pairing quantum dots with fullerenes for nanoscale photovoltaics 2Pairing quantum dots with fullerenes for nanoscale photovoltaics 3Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update 2Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update 3Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update 4Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update 5Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update 6Lactobacillus Beverage Confirmed to Reduce Fever Brought on by Acute Gastroenteritis Caused by Norovirus Infection 2Lactobacillus Beverage Confirmed to Reduce Fever Brought on by Acute Gastroenteritis Caused by Norovirus Infection 3
(Date:5/19/2013)... of electricity-producing bacteria that can grow using hydrogen gas ... its sole source of carbon. Researchers at the ... 113th General Meeting of the American Society for Microbiology. ... solely on hydrogen," says Amit Kumar, a researcher on ... of the Lovley Lab Group at the university. , ...
(Date:5/18/2013)... increasing number of U.S. children are experiencing gastrointestinal ... research presented at Digestive Disease Week (DDW). ... the Cleveland Clinic Children,s Hospital found that obese ... compared to their lean counterparts. The pattern showed ... be correlated to potential complications associated with obesity, ...
(Date:5/17/2013)... proteins in the brain responsible for protecting nerve cells ... increase cell survival. , The discovery, made by researchers ... the EMBO journal with additional comment in ... stroke and other brain diseases. , The research builds ... protein, known as SUMO, responsible for controlling the chemical ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2
... Addition to SAFsolution Product Family Simplifies the Addition ... Biometric Security to Thin-Client Identity Management., ... the,release of SAFsolution(R) Enterprise Citrix Web Authenticator, the ... security,solutions. SAFsolution Enterprise Citrix Web Authenticator takes the,standard ...
... announced they have discovered a previously unknown population of ... most endangered cat species, said World Wildlife Fund today. ... said Luis Suarez, head of WWFs Species Program in ... the Iberian lynx from imminent extinction. It appears ...
... The coal tit appears to live a strictly ... That,s only a facade. This indigenous songbird is among the ... at the University of Bonn shows. For this they have ... their young. In this way they were able to identify ...
Cached Biology News:IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 3Age increases chance of success as two-timer 2Age increases chance of success as two-timer 3
3'-O-Methylguanosine 5'-Triphosphate, Sodium, 1 umol. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
Recombinant Viral CCI/Fc Chimera, CF...
... ml. Improves reproducibility and quality ... streaking.Eliminates extra spots caused by ... throughout entire 2-D runs, ensuring ... for both analytical and preparative ...
LIVE/DEAD® Cell-Mediated Cytotoxicity Kit *for animal cells* *2000 assays*...
Biology Products: